HHealth Read More Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetesJanuary 28, 2026 More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D),…
HHealth Read More Bacterial metabolite enhances immune checkpoint therapy against lung cancerJanuary 15, 2026 UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response…
HHealth Read More Implanted vagus nerve stimulation device offers lasting relief for severe depressionJanuary 14, 2026 About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a…
HHealth Read More Real-time smartphone monitoring improves evaluation of insomnia treatment effectivenessJanuary 9, 2026 About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and…
HHealthcare Read More AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)January 9, 2026 Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…
HHealth Read More Women may derive greater long-term benefits from coronary artery bypass grafting compared with stentsDecember 22, 2025 Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits…
HHealth Read More High-dose rifampicin does not improve survival in tuberculosis meningitisDecember 18, 2025 Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in…
HHealth Read More UC Irvine receives funding for clinical trial of neural stem cell therapy for Huntington’s diseaseDecember 13, 2025 Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at…
HHealth Read More Dinutuximab beta plus chemotherapy shrinks neuroblastoma tumors in childrenDecember 13, 2025 Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has…
MMedication Read More Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trialDecember 12, 2025 In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…
BBusiness Read More Expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anemia patientsDecember 12, 2025 Friday, December 12, 2025 NIH clinical trial shows promise for people with treatment-limited, life-threatening disorder. A clinical trial…
HHealth Read More Targeted approach of immunotherapy improves sepsis outcomesDecember 8, 2025 Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient’s immune system condition. While…